Improving medication access within integrated treatment for individuals with co-occurring disorders in substance use treatment agencies

Improving medication access within integrated treatment for individuals with co-occurring disorders in substance use treatment agencies

Background The best approach to provide comprehensive care for individuals with co-occurring disorders (CODs) related to substance use and mental health is to address both disorders through an integrated treatment approach. However, only 25% of behavioral health agencies offer integrated care and &l...

Full description

Bibliographic Details
Main Authors:	James H Ford, Arveen Kaur, Deepika Rao, Aaron Gilson, Daniel M Bolt, Helene Chokron Garneau, Lisa Saldana, Mark P McGovern
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-09-01
Series:	Implementation Research and Practice
Online Access:	https://doi.org/10.1177/26334895211033659

Similar Items

What constitutes “behavioral health”? Perceptions of substance-related problems and their treatment in primary care
by: Ida Q. Chen, et al.
Published: (2020-07-01)

Stepped implementation-to-target: a study protocol of an adaptive trial to expand access to addiction medications
by: James H. Ford, et al.
Published: (2022-09-01)

Expanding access to medications for opioid use disorder in primary care clinics: an evaluation of common implementation strategies and outcomes
by: Hannah Cheng, et al.
Published: (2022-07-01)

Evaluating the Implementation of a Model of Integrated Behavioral Health in Primary Care: Perceptions of the Healthcare Team
by: Julia Alexandra Dunn, et al.
Published: (2023-01-01)

What Are Patient Preferences for Integrated Behavioral Health in Primary Care?
by: Julia Alexandra Dunn, et al.
Published: (2021-10-01)

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer
by: Lisa A. Rubinsak, et al.
Published: (2019-05-01)

Prevention Adaptation of an Evidence-Based Treatment for Parents Involved With Child Welfare Who Use Substances
by: Gracelyn Cruden, et al.
Published: (2021-11-01)

A Pilot Study Examining Access to and Satisfaction with Maternal Mental Health and Substance Use Disorder Treatment via Telemedicine
by: Constance Guille, et al.
Published: (2022-01-01)

Examining the role of social support in treatment for co-occurring substance use disorder and posttraumatic stress disorder
by: Amber M. Jarnecke, et al.
Published: (2022-06-01)

Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review
by: Alexandria S. Coles, et al.
Published: (2021-12-01)

Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment
by: Edith López-Toro, et al.
Published: (2022-05-01)

A Naturally Occurring Bovine Tauopathy Is Geographically Widespread in the UK.
by: Martin Jeffrey, et al.
Published: (2015-01-01)

Co-occurring intellectual disability and substance use disorders
by: Nita V Bhatt, et al.
Published: (2021-06-01)

Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors
by: Helle Wessel Andersson, et al.
Published: (2023-03-01)

Health Professionals’ Experiences with Treatment Engagement Among Immigrants with Co-occurring Substance Use- and Mental Health Disorders in Norway
by: Prabhjot Kour, et al.
Published: (2021-07-01)

Inequitable access to substance abuse treatment services in Cape Town, South Africa
by: Louw Johann, et al.
Published: (2010-11-01)

Identifying strategies to advance equitable implementation of co-occurring mental health and substance use disorder treatment in drug treatment courts: A study protocol
by: Ayorkor Gaba, et al.
Published: (2023-01-01)

Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial.
by: Suzette Glasner, et al.
Published: (2020-01-01)

Dopamine and sense of agency: Determinants in personality and substance use.
by: Anna Render, et al.
Published: (2019-01-01)

Treatment Experiences with Norwegian Health Care among Immigrant Men Living with Co-Occurring Substance Use- and Mental Health Disorders
by: Prabhjot Kour, et al.
Published: (2020-11-01)

Voice disorders occurred as a result of the use of psychoactive substances
by: Ilić-Savić Ivana S., et al.
Published: (2023-01-01)

Client perspectives on the accessibility and quality of substance use treatment during the COVID-19 pandemic
by: Randolph D. Hubach, et al.
Published: (2021-12-01)

Performance measurement for co-occurring mental health and substance use disorders
by: Pincus Harold A, et al.
Published: (2009-10-01)

Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.
by: Travis, S, et al.
Published: (2001)

Bank on your english : an elementary course in communication for bank employees /
by: 407473 McGovern, John, et al.
Published: (1987)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
by: McGovern, A, et al.
Published: (2016)

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

Refining a Digital Therapeutic Platform for Home Care Agencies in Dementia Care to Elicit Stakeholder Feedback: Focus Group Study With Stakeholders
by: Aaron Gilson, et al.
Published: (2022-03-01)

Comparative treatments of substance abuse /
by: Dowd, E. Thomas, et al.
Published: (1999)

Hybrid electrodialysis reverse osmosis system design and its optimization for treatment of highly saline brines
by: McGovern, Ronan Killian, et al.
Published: (2014)

Improving treatment of substance use disorders through community drug treatment clinics: An experiential account
by: Ravindra Rao, et al.
Published: (2021-01-01)

The Pandemic Experience for People with Depressive Symptoms: Substance Use, Finances, Access to Treatment, and Trusted Sources of Information
by: Katherine Sanchez, et al.
Published: (2022-09-01)

Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities
by: Kathryn E. Lancaster, et al.
Published: (2018-11-01)

The association between naturalistic use of psychedelics and co-occurring substance use disorders
by: Jonina Rabinowitz, et al.
Published: (2023-01-01)

Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances
by: Andreza R. Garcia, et al.
Published: (2019-01-01)

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

Use of machine learning to examine disparities in completion of substance use disorder treatment.
by: Aaron Baird, et al.
Published: (2022-01-01)

Determinants of outpatient substance use disorder treatment length-of-stay and completion: the case of a treatment program in the southeast U.S
by: Aaron Baird, et al.
Published: (2023-08-01)

Differences in persistence by class of oral therapy for the treatment of type 2 diabetes
by: McGovern, AP, et al.
Published: (2016)

Faith and agency on the Camino: walking between shared 'substance' and cultural (dis)appearance
by: Berg, A
Published: (2020)